Last reviewed · How we verify
Sequential therapy of atorvastatin
At a glance
| Generic name | Sequential therapy of atorvastatin |
|---|---|
| Sponsor | Zhang Qi, MD |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Traditional Chinese Medicine Intervention for Ischemic Cerebrovascular Disease and Diabetes Mellitus: An Efficacy Comparative Study (PHASE4)
- Sequential Therapy of Atorvastatin Improve Outcomes of ST-elevated Acute Myocardial Infarction (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Sequential therapy of atorvastatin CI brief — competitive landscape report
- Sequential therapy of atorvastatin updates RSS · CI watch RSS
- Zhang Qi, MD portfolio CI